Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Unavailable to recruit patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Breast-conserving surgery (BCS) is the traditional surgical treatment for early-stage breast cancer patients. There are evidences indicating that oncoplastic-BCS (displacement technique) could improve cosmetic outcomes and/or quality of life, and has similar oncological safety as traditional BCS does. However, there are no prospective trial comparing oncoplastic-BCS vs. traditional BCS in terms of cosmetic outcomes and oncological safety. In this study, the investigators are going to address this issue by assigning patients into traditional and oncoplastic-BCS group, based on their preference.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Traditional BCS | Breast-conserving surgery. Modified radical mastectomy. |
| |
| Oncoplastic-BCS | Breast-conserving surgery. Modified radical mastectomy. Oncoplastic-BCS based on surgeon preference and/or tumor location.
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Breast surgery | Procedure | Traditional breast-conserving surgery, oncoplastic breast-conserving surgery or modified radical mastectomy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Harvard/NSABP/RTOG breast cosmesis grading scale | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Positivity rate of cavity margin | Intraoperatively. | |
| Local-recurrence free survival | 5 years | |
| Disease free survival |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Non-metastatic breast cancer patients received surgical treatment in Sun Yat-sen Memorial Hospital, Sun Yat-sen University. Informed consent must be obtained for all of the included patients.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Erwei Song, M.D. Ph.D. | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Principal Investigator |
| Fengxi Su, M.D. | Yat-sen Memorial Hospital, Sun Yat-sen University. | Study Director |
Not provided
Not provided
| ID | Term |
|---|---|
| D015412 | Mastectomy, Segmental |
| D004358 | Drug Therapy |
| D011878 | Radiotherapy |
| ID | Term |
|---|---|
| D008408 | Mastectomy |
| D013514 | Surgical Procedures, Operative |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
| Chemotherapy or endocrine therapy or Trastuzumab therapy | Drug |
|
| Radiation therapy | Radiation |
|
| 5 years |
| Breast Cancer Treatment Outcome Scale (BCTOS) | 5 years |
| Morbidity | 1 year |